Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	24.72	28.7	30.76	26.72	53.03	101.97
Short-Term Investments	-	1.77	18.97	37.91	19.41	155.95
Cash & Short-Term Investments	24.72	30.47	49.73	64.63	72.44	257.92
Cash Growth	-62.56%	-38.73%	-23.04%	-10.79%	-71.91%	-14.52%
Receivables	448.26	419.59	377.51	389.24	390.53	484.99
Inventory	456.3	444.1	444.14	457.84	449.45	454.71
Prepaid Expenses	-	0.59	-	0.21	0.21	0.21
Other Current Assets	169.57	160.19	133.55	136.83	139.59	126.93
Total Current Assets	1,099	1,055	1,005	1,049	1,052	1,325
Property, Plant & Equipment	1,767	1,767	1,762	1,671	1,643	1,334
Other Long-Term Assets	0	-	-0	-0	0	0
Total Assets	2,865	2,822	2,767	2,720	2,696	2,659
Accounts Payable	9.25	9.6	9.75	12.33	16.15	16.58
Accrued Expenses	8.3	9.18	9.27	16.93	21.21	14.87
Current Portion of Leases	0.79	4.26	-	4.11	3.77	-
Current Income Taxes Payable	296.64	285.19	273.7	255.21	240.41	223.62
Other Current Liabilities	2.24	2.56	3.04	2.33	1.42	4.79
Total Current Liabilities	317.22	310.8	295.76	290.91	282.96	259.86
Long-Term Leases	5.36	5.31	-	-	4.11	-
Long-Term Deferred Tax Liabilities	154.27	153.71	151.73	150.21	140.5	152.3
Other Long-Term Liabilities	-	0	-0	-	0	-0
Total Liabilities	476.84	469.82	447.5	441.11	427.57	412.17
Common Stock	1,038	1,038	1,038	1,038	1,038	1,038
Retained Earnings	1,350	1,316	1,289	1,251	1,230	1,208
Comprehensive Income & Other	-	-1.15	-6.92	-10.69	-0.37	-
Shareholders' Equity	2,389	2,352	2,320	2,279	2,268	2,246
Total Liabilities & Equity	2,865	2,822	2,767	2,720	2,696	2,659
Total Debt	6.15	9.57	-	4.11	7.89	-
Net Cash (Debt)	18.57	20.9	49.73	60.51	64.56	257.92
Net Cash Growth	-65.80%	-57.97%	-17.82%	-6.26%	-74.97%	-14.52%
Net Cash Per Share	0.18	0.20	0.48	0.58	0.62	2.48
Filing Date Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Total Common Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Working Capital	781.64	744.14	709.17	757.83	769.27	1,065
Book Value Per Share	23.01	22.66	22.35	21.95	21.85	21.64
Tangible Book Value	2,389	2,352	2,320	2,279	2,268	2,246
Tangible Book Value Per Share	23.01	22.66	22.35	21.95	21.85	21.64
Land	-	74.85	74.85	74.85	74.85	74.85
Buildings	-	1,083	1,004	880.25	700.05	477.1
Machinery	-	1,576	1,524	1,443	1,320	1,317
Construction In Progress	-	128.1	174.96	197.38	394.59	243.52

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.